The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men (original) (raw)

Abstract

We recently demonstrated that natriuretic peptides and especially the atrial natriuretic peptide (ANP) are powerful lipolytic agents on isolated human fat cells. To search for a possible influence of obesity on ANP responsiveness, we compared the lipolytic effects of human ANP (h-ANP) on isolated subcutaneous abdominal adipose tissue (SCAAT) fat cells from young healthy lean and obese men. The lipid-mobilizing effects of an intravenous infusion of h-ANP was studied, as well as various metabolic and cardiovascular parameters that were compared in the same subjects. h-ANP (50 ng/min/kg) was infused iv for 60 min. Microdialysis probes were inserted in SCAAT to measure modifications of the extracellular glycerol concentrations during h-ANP infusion. Spectral analysis of blood pressure and heart rate oscillations that were recorded using digital photoplethysmography were used to assess changes in autonomic nervous system activity. h-ANP induced a marked and similar increase in glycerol and nonesterified fatty acids, and a weak increase in insulin plasma levels in lean and obese men. Plasma norepinephrine concentrations rose similarly during h-ANP infusion in lean and obese men. The effects of h-ANP infusion on the autonomic nervous system were similar in both groups, with an increase in the spectral energy of the low-frequency band of systolic blood pressure variability and a decrease in the spectral energy of the high-frequency band of heart rate. In SCAAT, h-ANP infusion increased extracellular glycerol concentration and decreased blood flow similarly in both groups. The increase in extracellular glycerol observed during h-ANP infusion was not modified when 0.1 mM propranolol was added to the microdialysis probe perfusate to prevent ␤ -adrenoceptor activation. These data show that ANP is a potent lipolytic hormone independent of the activation of the sympathetic nervous system, and that obesity did not modify the lipid-mobilizing effect of ANP in young obese subjects. -Galitzky, J., C. Sengenès, C. Thalamas, M. A. Marques, J-M. Senard, M. Lafontan, and M. Berlan. The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J. Lipid Res. 2001. 42: 536-544. Supplementary key words adipocyte • ANP • microdialysis • human fat cells Abbreviations: SCAAT, subcutaneous abdominal adipose tissue; ANP, atrial natriuretic peptide; NEFA, nonesterified fatty acids.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (34)

  1. De Bold, A., J. Bornstein, H. B. Veress, and A. T. Sonnenberg. 1981. A rapid and potent natriuretic response to intravenous injec- tion of atrial myocardial extracts in rats. Life Sci. 28: 89-94.
  2. Sudoh, T., K. Kangawa, N. Minamino, and H. Matsuo. 1988. A new natriuretic peptide in porcine brain. Nature. 332: 78-81.
  3. Sudoh, T., N. Minamino, K. Kangawa, and H. Matsuo. 1990. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168: 645-651.
  4. De Leon, H., M-C. Bonhomme, G. Thibault, and R. Garcia. 1995. Localization of atrial natriuretic factor receptors in the mesenteric arterial bed. Circ. Res. 77: 64-71.
  5. Göke, R., B. Göke, B. Noll, G. Richter, H. Christoph-Fehmann, and R. Arnold. 1989. Receptors for atrial natriuretic peptide on isolated rat adipocytes. Biomed. Res. 10: 463-467.
  6. Jeandel, L., H. Okamura, M. Belles-Isles, J-G. Chabot, F. Dihl, G. Morel, P-A. Kelly, and S. Heisler. 1988. Immunocytochemical local- ization, binding, and effects of atrial natriuretic peptide in rat adi- pocytes. Mol. Cell. Endocrinol. 62: 69-78.
  7. Sarzani, R., V. M. Paci, C. M. Zingaretti, C. Pierleoni, S. Cinti, G. Cola, A. Rappelli, and P. Dessi-Fulgheri. 1995. Fasting inhibits natriuretic peptide clearance receptor expression in rat adipose tissue. J. Hypertens. 13: 1241-1246.
  8. Sarzani, R., P. Dessi-Fulgheri, V. M. Paci, E. Espinosa, and A. Rap- pelli. 1996. Expression of natriuretic peptide receptors in human adipose and other tissues. J. Endocrinol. Invest. 19: 581-585.
  9. Thibault, G., A. Lacasse, and R. Garcia. 1996. Specific potentiation by cyclic AMP of natriuretic peptide-mediated cyclic GMP produc- tion in adipose tissue. Life Sci. 58: 2345-2353.
  10. Sengenès, C., B. Berlan, I. De Glisezinski, M. Lafontan, and J. Gal- itzky. 2000. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 14: 1345-1351.
  11. Weidmann, P., M. P. Gnädinger, H. R. Ziswiler, S. Shaw, C. Bach- mann, W. Rascher, D. E. Uehlinger, L. Hasler, and F. C. Reubi. 1986. Cardiovascular, endocrine and renal effects of atrial natri- uretic peptide in essential hypertension. J. Hypertens. 4: S71-S83.
  12. Uehlinger, D. E., P. Weidmann, M. P. Gnädinger, L. Hasler, C. Bachmann, S. Shaw, B. Hellmüller, and R. E. Lang. 1986. Increase in circulating insulin induced by atrial natriuretic peptide in nor- mal humans. J. Cardiovasc. Pharmacol. 8: 1122-1129.
  13. Felländer, G., B. Linde, and J. Bolinder. 1996. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int. J. Obesity. 20: 220-226.
  14. Galitzky, J., M. Lafontan, J. Nordenström, and P. Arner. 1993. Role of vascular alpha2-adrenoceptors in regulating lipid mobilization from human adipose tissue. J. Clin. Invest. 91: 1997-2003.
  15. Enoksson, S., J. Nordenström, J. Bolinder, and P. Arner. 1995. In- fluence of local blood flow on glycerol levels in human adipose tis- sue. Int. J. Obesity. 19: 350-354.
  16. Barbe, P., L. Millet, J. Galitzky, M. Lafontan, and M. Berlan. 1996. In situ assessment of the role of the ␤1-, ␤2-and ␤3-adrenoceptors in the control of lipolysis and nutritive blood flow in human sub- cutaneous adipose tissue. Br. J. Pharmacol. 117: 907-913.
  17. De Glisezinski, I., I. Harant, F. Crampes, F. Trudeau, A. Felez, J. M. Cottet-Emard, D. Rivière, and M. Garrigue. 1998. Effect of carbo- hydrate ingestion on adipose tissue lipolysis during long-lasting ex- ercise in trained men. J. Appl. Physiol. 84: 1627-1632.
  18. Stich, V., I. De Glisezinski, F. Crampes, J. Hejnova, J. M. Cottet- Emard, J. Galitzky, M. Lafontan, D. Riviere, and M. Berlan. 2000. Activation of ␣2-adrenergic receptors impairs exercise-induced li- polysis in subcutaneous adipose tissue of obese subjects. Am. J. Physiol. 279: R499-R504.
  19. Rodbell, M. 1964. Metabolism of isolated fat cells. I. Effects of hor- mones on glucose metabolism and lipolysis. J. Biol. Chem. 29: 375- 380.
  20. Bernst, E., and I. Gutman. 1974. Determination of ethanol with al- cohol dehydrogenase and NAD. In Methods of Enzymatic Analysis. Vol. 3. H. U. Bergmeyer, editor. Verlag, Weinheim. 1499-1505.
  21. Bradley, D. C., and H. R. Kaslow. 1989. Radiometric assays for glyc- erol, glucose, and glycogen. Anal. Biochem. 180: 11-16.
  22. Millet, L., P. Barbe, M. Lafontan, M. Berlan, and J. Galitzky. 1998. Catecholamine effects on lipolysis and blood flow in human ab- dominal and femoral adipose tissue. J. Appl. Physiol. 85: 148-157.
  23. Galitzky, J., M. Taouis, M. Berlan, D. Riviere, M. Garrigues, and M. Lafontan. 1988. Alpha2-antagonist compounds and lipid mobiliza- tion: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volonteers. Eur. J. Clin. Invest. 18: 587-594.
  24. Arner, P., E. Kriegholm, P. Engfeldt, and J. Bolinder. 1990. Adren- ergic regulation of lipolysis in situ at rest and during exercise. J. Clin. Invest. 85: 893-898.
  25. Arner, P., E. Kriegholm, and P. Engfeldt. 1991. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. J. Pharmacol. Exp. Ther. 259: 317-322.
  26. Roach, P. J., J. S. Sanders, W. J. Berg, A. L. Mark, T. J. Ebert, and D. W. Fergusson. 1990. Pathophysiologic levels of atrial natriuretic factor do not alter reflex sympathetic control: direct evidence from microneurographic studies in humans. J. Am. Coll. Cardiol. 15: 1318-1330.
  27. Floras, J. S. 1990. Sympathoinhibitory effects of atrial natruretic factor in normal humans. Circulation. 81: 1860-1873.
  28. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid. Res. 34: 1057-1091.
  29. Large, V., L. Hellström, S. Reynisdottir, F. Lönnqvist, P. Eriksson, L. Lannfelt, and P. Arner. 1997. Human beta2-adrenoceptor gene polymorphisms are highly frequent in obesity and associated with altered adipocyte beta2-adrenoceptor function. J. Clin. Invest. 100: 3005-3013.
  30. Mauriège, P., J-P. Després, D. Prud'homme, M. C. Pouliot, M. Mar- cotte, A. Tremblay, and C. Bouchard. 1991. Regional variation in adipose tissue lipolysis in lean and obese men. J. Lipid Res. 32: 1625-1633.
  31. Dessi-Fulgheri, P., R. Sarzani, P. Tamburrini, A. Moraca, E. Espi- nosa, G. Cola, L. Giantomassi, and A. Rappelli. 1997. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expres- sion in adipose tissue of normotensive and hypertensive obese pa- tients. J. Hypertens. 15: 1695-1699.
  32. Dessi-Fulgheri, P., R. Sarzani, M. Serenelli, P. Tamburrini, D. Spag- nolo, L. Giantomassi, E. Espinosa, and A. Rappelli. 1999. Low calo- rie diet enhances renal, hemodynamic, and humoral effects of ex- ogenous atrial natriuretic peptide in obese hypertensives. Hypertension. 33: 658-662.
  33. Laychock, S. G. 1981. Evidence for guanosine 3Ј,5Ј-monophos- phate as a putative mediator of insulin secretion from isolated rat islet. Endocrinology. 108: 1197-1205.
  34. Summers, L. K. M., J. S. Samra, S. M. Humphreys, R. J. Morris, and K. N. Frayn. 1996. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin. Sci. 91: 679-683.